undefined
EUTM file information

018901287

CORRECTSEQ TX


July 13, 2023

Trademark Summary

The trademark application CORRECTSEQ TX was filed by CorrectSequence Therapeutics Co., Ltd, a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on September 28, 2023, and it was registered by office on January 5, 2024 without any oppositions.

The application was filed in English (Italian was selected as the second language).

Change of name and professional address of the trademark registration was recorded on November 13, 2024.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations
    2. Biological preparations for medical purposes
    3. Surgical implants comprised of living tissues
    4. Stem cells for medical purposes
    5. Biological tissue cultures for medical purposes
    6. Immunostimulants
    7. Pre-filled syringes for medical purposes
    8. Human allogeneic tissues
    9. Medical cell
    10. Biochemicial drug
    11. Blood products
    12. Living cells for medical purposes
    13. Reagents for medical purposes
    14. Medical cell function activating drug
    15. Medical cell inhibitor
    16. Graft (living tissue)
    17. Vaccine preparations
    18. Diagnostic reagents for medical purposes
    19. Diagnostic preparations for medical and veterinary use.
  • The mark was filed in class 42 with following description of goods:
    1. Technological research
    2. Technical project studies
    3. Scientific research
    4. Biological research
    5. Clinical trials
    6. Medical research
    7. Culturing of cells for scientific research purposes
    8. Scientific research in the field of genetics
    9. Medical laboratory service
    10. Genetic screening [for scientific purposes]
    11. Biological cloning services
    12. Biological research and analysis
    13. Stem cell research services
    14. Structural and functional analysis of genomes
    15. Research and development of antibodies
    16. Genetic testing for scientific research
    17. Biotechnological research
    18. Medical research service
    19. Development of pharmaceutical preparations and pharmaceuticals
    20. Biomedical research
    21. DNA screening (for scientific research purposes)
    22. Pharmaceutical research
    23. Research services relating to medicines
    24. Drug development
    25. Vaccine research and development services
    26. Cell culture services for scientific and research purposes for others
    27. Genetic testing of laboratory animals for research purposes
    28. Research in the field of DNA repair technology
    29. Research in the field of genome editing.
  • The mark was filed in class 44 with following description of goods:
    1. Therapy services
    2. Medical analysis services for diagnostic and treatment purposes provided by medical laboratories
    3. Medical treatment using cultured cells
    4. Cultured cell bank services for medical transplantation
    5. Stem cell therapy services
    6. Genetic testing for medical purposes
    7. DNA screening (for medical purposes)
    8. Medical services relating to the removal, treatment and processing of human cells
    9. Medical services relating to the removal, treatment and processing of human blood
    10. Medical services relating to the removal, treatment and processing of stem cells
    11. Stem cell bank services
    12. Immunodetection services (for medical purposes).